Posted 17 July, 2023
Apogee Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:APGE in a 424B4 filed on 17 July, 2023.
This is our initial public offering and prior to this offering, no public market existed for our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Apogee Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in February 2022 and is headquartered in Waltham, MA.Market Cap
$2.12B
View Company Details
$2.12B
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.